Recently, Oviva has raised $21 million (approx €19 million) in Series B funding led by MTIP with participation from new investor Earlybird and existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech.
This Swiss firm digitising treatment of type 2 diabetes through personalised behavior change programmes secures €19M